Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

The epidemiology of sepsis in the United States from 1979 through 2000

Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841 · see citing works

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · see citing works

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116 · see citing works

Targeting multidrug resistance in cancer

Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609 · see citing works

Fungal secondary metabolism — from biochemistry to genomics

Keller, N. P., Turner, G., & Bennett, J. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1286 · Cited by 1,736 · see citing works

Regulation of Signaling Protein Function and Trafficking by the hsp90/hsp70-Based Chaperone Machinery 1

Pratt, W., & Toft, D. (2003) · Experimental biology and medicine · doi:10.1177/153537020322800201 · Cited by 1,539 · see citing works

Multidrug-resistance efflux pumps ? not just for resistance

Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,523 · see citing works

Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.

Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444 · see citing works

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380 · see citing works

Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · see citing works

A kingdom-level phylogeny of eukaryotes based on combined protein data.

Baldauf, S., Roger, A., Wenk-Siefert, I., & Doolittle, W. (2000) · Science · doi:10.1126/science.290.5493.972 · Cited by 1,243 · see citing works

Bacteriocins: Evolution, Ecology, and Application

Riley, M. A., & Wertz, J. E. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.161024 · Cited by 1,236 · see citing works

Antifungal agents: mechanisms of action

Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202 · see citing works

Cell Wall Integrity Signaling in <i>Saccharomyces cerevisiae</i>

Levin, D. E. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.2.262-291.2005 · Cited by 1,136 · see citing works

Echinocandin antifungal drugs

Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131 · see citing works

Structure and mechanism of the Hsp90 molecular chaperone machinery

Pearl, L. H., & Prodromou, C. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142738 · Cited by 1,103 · see citing works

Natural Products from Plant-Associated Microorganisms:  Distribution, Structural Diversity, Bioactivity, and Implications of Their Occurrence

Gunatilaka, A. A. L. (2006) · Journal of Natural Products · doi:10.1021/np058128n · Cited by 1,032 · see citing works

Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.

Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980403y · Cited by 1,004 · see citing works

Bacterial Small-Molecule Signaling Pathways

Camilli, A., & Bassler, B. L. (2006) · Science · doi:10.1126/science.1121357 · Cited by 978 · see citing works

Anidulafungin versus Fluconazole for Invasive Candidiasis

Reboli, A. C., Rotstein, C., Pappas, P. G., Chapman, S. W., Kett, D. H., Kumar, D., Betts, R., Wible, M., Goldstein, B. P., Schranz, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066906 · Cited by 894 · see citing works

Multiple molecular mechanisms for multidrug resistance transporters

Higgins, C. F. (2007) · Nature · doi:10.1038/nature05630 · Cited by 863 · see citing works

Cell Wall Assembly in <i>Saccharomyces cerevisiae</i>

Lesage, G., & Bussey, H. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00038-05 · Cited by 849 · see citing works

Hsp90

Young, J. C., Moarefi, I., & Hartl, F. U. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104079 · Cited by 826 · see citing works

Heat-shock protein 90, a chaperone for folding and regulation

Picard, D. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012491 · Cited by 797 · see citing works

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis

Zaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005) · Clinical Infectious Diseases · doi:10.1086/496922 · Cited by 784 · see citing works

Aneuploidy and Isochromosome Formation in Drug-Resistant <i>Candida albicans</i>

Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733 · see citing works

Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi

Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · see citing works

Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatus

Pfaller, M. A., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4419-4431.2004 · Cited by 695 · see citing works

Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997

McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases · doi:10.1086/322606 · Cited by 657 · see citing works

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

Weisberg, E., Manley, P. W., Cowan‐Jacob, S. W., Hochhaus, A., & Griffin, J. D. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2126 · Cited by 631 · see citing works

Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus

White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612 · see citing works

New aspects of natural products in drug discovery

Lam, K. S. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.04.001 · Cited by 531 · see citing works

How to build a biofilm: a fungal perspective

Blankenship, J. R., & Mitchell, A. P. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.10.003 · Cited by 530 · see citing works

Resistance to echinocandin-class antifungal drugs.

Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512 · see citing works

Itraconazole resistance in Aspergillus fumigatus

Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A., Warnock, D. W., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1364 · Cited by 507 · see citing works

Antibiotics as signalling molecules

Yim, G., Wang, H. H., & Julian Davies, F. R. S. (2007) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2007.2044 · Cited by 496 · see citing works

A New <i>Aspergillus fumigatus</i> Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of <i>cyp51A</i> Alterations

Mellado, E., Garcia-Effron, G., Alcázar-Fuoli, L., Melchers, W. J. G., Verweij, P. E., Cuenca-Estrella, M., & Rodríguez-Tudela, J. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01092-06 · Cited by 490 · see citing works

Amphotericin B: spectrum and resistance

Ellis, D. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.7 · Cited by 474 · see citing works

Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in <i>Candida albicans</i> Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients

Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470 · see citing works

Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

Sanglard, D., Ischer, F., Koymans, L. M. H., & Billé, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465 · see citing works

Molecular basis of resistance to azole antifungals.

Lupetti, A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02280-3 · Cited by 449 · see citing works

Identification of Yeast Rho1p GTPase as a Regulatory Subunit of 1,3-β-Glucan Synthase

Qadota, H., Python, C. P., Inoue, S., Arisawa, M., Anraku, Y., Zheng, Y., Watanabe, T., Levin, D. E., & Ohya, Y. (1996) · Science · doi:10.1126/science.272.5259.279 · Cited by 445 · see citing works

Calcineurin acts through the<i>CRZ1/TCN1</i>-encoded transcription factor to regulate gene expression in yeast

Stathopoulos, A. M., & Cyert, M. S. (1997) · Genes &amp; Development · doi:10.1101/gad.11.24.3432 · Cited by 442 · see citing works

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434 · see citing works

Bacterial resistance to antibiotics: Modified target sites

Lambert, P. A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.003 · Cited by 431 · see citing works

Differential Expression and Function of Two Homologous Subunits of Yeast 1,3-β-D-Glucan Synthase

Mazur, P., Morin, N. R., Baginsky, W. F., El-Sherbeini, M., Clemas, J. A., NIELSEN, J. B. K., & Foor, F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5671 · Cited by 425 · see citing works

Sensing the environment: lessons from fungi

Bahn, Y., Xue, C., Idnurm, A., Rutherford, J. C., Heitman, J., & Cardenas, M. E. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1578 · Cited by 416 · see citing works

Putative Role of β-1,3 Glucans in <i>Candida albicans</i> Biofilm Resistance

Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01056-06 · Cited by 407 · see citing works

<i>TAC1</i> , Transcriptional Activator of <i>CDR</i> Genes, Is a New Transcription Factor Involved in the Regulation of <i>Candida albicans</i> ABC Transporters <i>CDR1</i> and <i>CDR2</i>

Coste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407 · see citing works

Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000

Pfaller, M. A., Messer, S. A., Hollis, R. J., & Jones, R. N. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1032-1037.2002 · Cited by 402 · see citing works

The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase.

Douglas, C. M., Foor, F., Marrinan, J. A., Morin, N., Nielsen, J. B., Dahl, A. M., Mazur, P., Baginsky, W., Li, W., & el-Sherbeini, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12907 · Cited by 401 · see citing works

<i>Candida albicans</i> Mutations in the Ergosterol Biosynthetic Pathway and Resistance to Several Antifungal Agents

Sanglard, D., Ischer, F., Parkinson, T., Falconer, D., & Bille, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2404-2412.2003 · Cited by 398 · see citing works

Cryptococcosis

Chayakulkeeree, M., & Perfect, J. R. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.07.001 · Cited by 396 · see citing works

A Mutation in Tac1p, a Transcription Factor Regulating <i>CDR1</i> and <i>CDR2</i> , Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in <i>Candida albicans</i>

Coste, A., Turner, V., Ischer, F., Morschhäuser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., & Sanglard, D. (2006) · Genetics · doi:10.1534/genetics.105.054767 · Cited by 385 · see citing works

Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans

Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., Borgers, M., Ramaekers, F. C. S., Odds, F. C., & Vanden Bossche, H. (1999) · Microbiology · doi:10.1099/00221287-145-10-2701 · Cited by 382 · see citing works

Multiple-Triazole–Resistant Aspergillosis

Verweij, P. E., Mellado, E., & Melchers, W. J. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmc061720 · Cited by 380 · see citing works

Evolution of antifungal-drug resistance: mechanisms and pathogen fitness

Anderson, J. B. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1179 · Cited by 375 · see citing works

The direct cost and incidence of systemic fungal infections

Wilson, L. S., Reyes, C. M., Stolpman, M., Speckman, J., Allen, K., & Beney, J. (2002) · Value in Health · doi:10.1046/j.1524-4733.2002.51108.x · Cited by 374 · see citing works

The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans

Morschhäuser, J., Barker, K. S., Liu, T. T., Blaß-Warmuth, J., Homayouni, R., & Rogers, P. D. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030164 · Cited by 355 · see citing works

Resistance to fluconazole and cross‐resistance to amphotericin B in <i>Candida albicans</i> from AIDS patients caused by defective sterol Δ^5,6‐desaturation

Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351 · see citing works

Cyclic AMP-Dependent Protein Kinase Regulates Pseudohyphal Differentiation in Saccharomyces cerevisiae

Pan, X., & Heitman, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4874 · Cited by 350 · see citing works

Calcineurin A of <i>Candida albicans</i>: involvement in antifungal tolerance, cell morphogenesis and virulence

Sanglard, D., Ischer, F., Marchetti, O., Entenza, J., & Bille, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03495.x · Cited by 350 · see citing works

Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors

Douglas, C. M., D'Ippolito, J. A., Shei, G.-J., Meinz, M., Onishi, J. C., Marrinan, J. A., Li, W., Abruzzo, G. K., Flattery, A. M., Bartizal, K. F., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2471 · Cited by 344 · see citing works

Calcineurin is essential for survival during membrane stress in Candida albicans

Cruz, M. C., Goldstein, A. L., Blankenship, J. R., Del Poeta, M., Davis, D., Cardenas, M. E., Perfect, J. R., McCusker, J. H., & Heitman, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.546 · Cited by 342 · cited 3× · see citing works

Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical <i>Candida albicans</i> Strains

Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., & Morschhäuser, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3065 · Cited by 339 · see citing works

Natural products — The future scaffolds for novel antibiotics?

Butler, M. S., & Buss, A. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.012 · Cited by 338 · see citing works

The three yeast A kinases have specific signaling functions in pseudohyphal growth

Robertson, L. S., & Fink, G. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13783 · Cited by 329 · see citing works

An isochromosome confers drug resistance <i>in vivo</i> by amplification of two genes, <i>ERG11</i> and <i>TAC1</i>

Selmecki, A., Gerami‐Nejad, M., Paulson, C., Forche, A., & Berman, J. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06176.x · Cited by 325 · see citing works

Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.

Steinbach, W. J., Reedy, J. L., Cramer, R. A., Perfect, J. R., & Heitman, J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1680 · Cited by 313 · see citing works

Genome-Wide Expression Profiling of the Response to Azole, Polyene, Echinocandin, and Pyrimidine Antifungal Agents in<i>Candida albicans</i>

Liu, T. T., Lee, R. E. B., Barker, K. S., Lee, R. E., Wei, L., Homayouni, R., & Rogers, P. D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2226-2236.2005 · Cited by 313 · see citing works

The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.

Cowen, L. E. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1835 · Cited by 311 · see citing works

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

Bartizal, K. F., Gill, C. J., Abruzzo, G. K., Flattery, A. M., Kong, L., Scott, P. M., Smith, J. G., Leighton, C., Bouffard, A., Dropinski, J. F., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2326 · Cited by 311 · see citing works

The PKC, HOG and Ca ²⁺ signalling pathways co‐ordinately regulate chitin synthesis in <i>Candida albicans</i>

Munro, C. A., Selvaggini, S., De Bruijn, I., Walker, L., Lenardon, M. D., Gerssen, B., Milne, S., Brown, A. J. P., & Gow, N. A. R. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05588.x · Cited by 309 · see citing works

Identification of Two Different 14-α Sterol Demethylase-Related Genes ( <i>cyp51A</i> and <i>cyp51B</i> ) in <i>Aspergillus fumigatus</i> and Other <i>Aspergillus</i> species

Mellado, E., Diaz-Guerra, T. M., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.7.2431-2438.2001 · Cited by 307 · see citing works

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

Pachl, J., Svoboda, P., Jacobs, F., Vandewoude, K., van der Hoven, B., Spronk, P., Masterson, G., Malbrain, M., Aoun, M., Garbino, J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/503428 · Cited by 307 · see citing works

Small molecules: the missing link in the central dogma

Schreiber, S. L. (2005) · Nature Chemical Biology · doi:10.1038/nchembio0705-64 · Cited by 306 · see citing works

Genotypic Evolution of Azole Resistance Mechanisms in Sequential <i>Candida albicans</i> Isolates

Coste, A., Selmecki, A., Forche, A., Diogo, D., Bougnoux, M.-E., d'Enfert, C., Berman, J., & Sanglard, D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00151-07 · Cited by 305 · see citing works

Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

Cuenca-Estrella, M., Gomez-Lopez, A., Mellado, E., Buitrago, M. J., Monzon, A., & Rodriguez-Tudela, J. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.917-921.2006 · Cited by 298 · see citing works

Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases

Steinbach, W. J., Benjamin, D. K., Kontoyiannis, D. P., Perfect, J. R., Lutsar, I., Marr, K. A., Lionakis, M. S., Torres, H. A., Jafri, H. S., & Walsh, T. J. (2004) · Clinical Infectious Diseases · doi:10.1086/421950 · Cited by 294 · see citing works

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

Denning, D. W., Marr, K. A., Lau, W. M., Facklam, D., Ratanatharathorn, V., Becker, C., Ullmann, A. J., Seibel, N. L., Flynn, P. M., van Burik, J. H., et al. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.03.003 · Cited by 293 · see citing works

Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against <i>Candida albicans</i> , <i>Candida glabrata</i> , and <i>Candida krusei</i>

Onyewu, C., Blankenship, J. R., Del Poeta, M., & Heitman, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.956-964.2003 · Cited by 282 · see citing works

Genetics and genomics of Candida albicans biofilm formation

Nobile, C. J., & Mitchell, A. P. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00761.x · Cited by 281 · see citing works

A Point Mutation in the 14α-Sterol Demethylase Gene <i>cyp51A</i> Contributes to Itraconazole Resistance in <i>Aspergillus fumigatus</i>

Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1120-1124.2003 · Cited by 281 · see citing works

Epidemiology and outcome of infections due to Aspergillus terreus : 10‐year single centre experience

Lass‐Flörl, C., Grif, K., Mayr, A., Petzer, A., Gastl, G., Bonatti, H., Freund, M. C., Kropshofer, G., Dierich, M. P., & Nachbaur, D. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05763.x · Cited by 264 · see citing works

Calcineurin Controls Growth, Morphology, and Pathogenicity in <i>Aspergillus fumigatus</i>

Steinbach, W. J., Cramer, R. A., Perfect, B. Z., Asfaw, Y. G., Sauer, T. C., Najvar, L. K., Kirkpatrick, W. R., Patterson, T. F., Benjamin, D. K., Heitman, J., et al. (2006) · Eukaryotic Cell · doi:10.1128/ec.00139-06 · Cited by 264 · see citing works

Talking to Themselves: Autoregulation and Quorum Sensing in Fungi

Hogan, D. A. (2006) · Eukaryotic Cell · doi:10.1128/ec.5.4.613-619.2006 · Cited by 259 · see citing works

Multiple Resistance Mechanisms among Aspergillus fumigatus Mutants with High-Level Resistance to Itraconazole

do Nascimento, A. M., Goldman, G. H., Park, S., Marras, S. A. E., Delmas, G., Oza, U., Lolans, K., Dudley, M. N., Mann, P. A., & Perlin, D. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1719-1726.2003 · Cited by 256 · see citing works

In Vitro Amphotericin B Resistance in Clinical Isolates of Aspergillus terreus , with a Head-to-Head Comparison to Voriconazole

Sutton, D. A., Sanche, S. E., Revankar, S. G., Fothergill, A. W., & Rinaldi, M. G. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2343-2345.1999 · Cited by 254 · see citing works

Potent Synergism of the Combination of Fluconazole and Cyclosporine in <i>Candida albicans</i>

Marchetti, O., Moreillon, P., Glauser, M. P., Bille, J., & Sanglard, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2373-2381.2000 · Cited by 252 · see citing works

Experimental Pulmonary Aspergillosis Due toAspergillus terreus:Pathogenesis and Treatment of an Emerging Fungal Pathogen Resistant to Amphotericin B

Walsh, T. J., Petraitis, V., Petraitienė, R., Field‐Ridley, A., Sutton, D. A., Ghannoum, M. A., Sein, T., Schaufele, R. L., Peter, J., Bacher, J. D., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/377210 · Cited by 252 · see citing works

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

Abruzzo, G. K., Flattery, A. M., Gill, C. J., Kong, L., Smith, J. G., Pikounis, V. B., Balkovec, J. M., Bouffard, A., Dropinski, J. F., Rosen, H., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2333 · Cited by 241 · see citing works

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection

Denning, D. W. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.401 · Cited by 234 · see citing works

Preclinical Assessment of the Efficacy of Mycograb, a Human Recombinant Antibody against Fungal HSP90

Matthews, R., Rigg, G. P., Hodgetts, S. J., Carter, T., Chapman, C. J., Gregory, C. A., Illidge, C., & Burnie, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2208-2216.2003 · Cited by 232 · see citing works

<i>CRZ1</i> , a target of the calcineurin pathway in <i>Candida albicans</i>

Karababa, M., Valentino, E., Pardini, G., Coste, A. T., Bille, J., & Sanglard, D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.05037.x · Cited by 231 · see citing works

A Unique Fungal Two-Component System Regulates Stress Responses, Drug Sensitivity, Sexual Development, and Virulence of Cryptococcus neoformans

Bahn, Y., Kojima, K., Cox, G. M., & Heitman, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-02-0113 · Cited by 231 · see citing works

Assessing Resistance to the Echinocandin Antifungal Drug Caspofungin in <i>Candida albicans</i> by Profiling Mutations in <i>FKS1</i>

Balashov, S. V., Park, S., & Perlin, D. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01653-05 · Cited by 225 · see citing works

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis

Lass‐Flörl, C., Kofler, G., Kropshofer, G., Hermans, J., Kreczy, A., Dierich, M. P., & Niederwieser, D. W. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.4.497 · Cited by 223 · see citing works

Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia

Nolte, F. S., Parkinson, T., Falconer, D. J., Dix, S. P., Williams, J. M., Gilmore, C., Geller, R., & Wingard, J. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.196 · Cited by 219 · see citing works

The <i>Cryptococcus neoformans</i> MAP kinase Mpk1 regulates cell integrity in response to antifungal drugs and loss of calcineurin function

Kraus, P. R., Fox, D. S., Cox, G. M., & Heitman, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03508.x · Cited by 217 · see citing works

Candida albicans biofilm development, modeling a host–pathogen interaction

Nett, J., & Andes, D. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.007 · Cited by 210 · see citing works

Substitutions at Methionine 220 in the 14α-Sterol Demethylase (Cyp51A) of <i>Aspergillus fumigatus</i> Are Responsible for Resistance In Vitro to Azole Antifungal Drugs

Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2747-2750.2004 · Cited by 210 · see citing works

Temperature-Induced Expression of Yeast <i>FKS2</i> Is under the Dual Control of Protein Kinase C and Calcineurin

Zhao, C., Jung, U. S., Garrett-Engele, P., Roe, T., Cyert, M. S., & Levin, D. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.1013 · Cited by 209 · see citing works

Candida albicans drug resistance—Another way to cope with stress

Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Tanabe, K., Niimi, M., & Monk, B. C. (2007) · Microbiology · doi:10.1099/mic.0.2007/010405-0 · Cited by 208 · see citing works

Evolution of Drug Resistance in Experimental Populations of <i>Candida albicans</i>

Cowen, L. E., Sanglard, D., Calabrese, D., Sirjusingh, C., Anderson, J. B., & Kohn, L. M. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.6.1515-1522.2000 · Cited by 207 · see citing works

Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004)

Pfaller, M. A., Messer, S. A., Boyken, L. B., Rice, C., Tendolkar, S., Hollis, R. J., Doern, G. V., & Diekema, D. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.5.2163-2167.2005 · Cited by 205 · see citing works

Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate

Slaven, J. W., Anderson, M. J., Sanglard, D., Dixon, G. K., Bille, J., Roberts, I. S., & Denning, D. W. (2002) · Fungal Genetics and Biology · doi:10.1016/s1087-1845(02)00016-6 · Cited by 202 · see citing works

Multi-azole resistance in Aspergillus fumigatus

Howard, S. J., Webster, I., Moore, C. B., Gardiner, R. E., Park, S., Perlin, D. S., & Denning, D. W. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.017 · Cited by 202 · see citing works

The G Protein-coupled Receptor Gpr1 and the Gα Protein Gpa2 Act through the cAMP-Protein Kinase A Pathway to Induce Morphogenesis in Candida albicans

Maidan, M. M., Rop, L. D., Serneels, J., Exler, S., Rupp, S., Tournu, H., Thevelein, J. M., & Dijck, P. V. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-09-0780 · Cited by 202 · see citing works

Alexander Fleming and the discovery of penicillin

Bennett, J. W., & Chung, K.-T. (2001) · Advances in applied microbiology · doi:10.1016/s0065-2164(01)49013-7 · Cited by 201 · see citing works

Susceptibility of Cryptococcus neoformans Biofilms to Antifungal Agents In Vitro

Martinez, L. R., & Casadevall, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1021-1033.2006 · Cited by 200 · see citing works

A Glucan Synthase <i>FKS1</i> Homolog in <i>Cryptococcus neoformans</i> Is Single Copy and Encodes an Essential Function

Thompson, J. R., Douglas, C. M., Li, W., Jue, C. K., Pramanik, B., Yuan, X., Rude, T. H., Toffaletti, D. L., Perfect, J. R., & Kurtz, M. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.2.444-453.1999 · Cited by 196 · see citing works

The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling.

Reinoso-Martín, C., Schüller, C., Schuetzer-Muehlbauer, M., & Kuchler, K. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.6.1200-1210.2003 · Cited by 193 · see citing works

Escape of <i>Candida</i> from Caspofungin Inhibition at Concentrations above the MIC (Paradoxical Effect) Accomplished by Increased Cell Wall Chitin; Evidence for β-1,6-Glucan Synthesis Inhibition by Caspofungin

Stevens, D. A., Ichinomiya, M., Koshi, Y., & Horiuchi, H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00563-06 · Cited by 193 · see citing works

The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced Affinity

Lamb, D. C., Kelly, D. E., Schunck, W., Shyadehi, A. Z., Akhtar, M., Lowe, D. J., Baldwin, B. C., & Kelly, S. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5682 · Cited by 192 · see citing works

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis

Laverdière, M., LALONDE, R. G., Baril, J.-G., Sheppard, D. C., Park, S., & Perlin, D. S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl022 · Cited by 192 · see citing works

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia

Ostrosky-Zeichner, L., Kontoyiannis, D., Raffalli, J., Mullane, K. M., Vazquez, J., Anaissie, E. J., Lipton, J., Jacobs, P., Rensburg, J. H. J., Rex, J. H., et al. (2005) · European Journal of Clinical Microbiology &amp; Infectious Diseases · doi:10.1007/s10096-005-0024-8 · Cited by 189 · see citing works

Mutations in Aspergillus fumigatus Resulting in Reduced Susceptibility to Posaconazole Appear To Be Restricted to a Single Amino Acid in the Cytochrome P450 14α-Demethylase

Mann, P. A., Parmegiani, R. M., Wei, S.-Q., Mendrick, C. A., Li, X., Loebenberg, D., DiDomenico, B., Hare, R. S., Walker, S. S., & McNicholas, P. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.577-581.2003 · Cited by 188 · see citing works

Calcineurin Is Essential for <i>Candida albicans</i> Survival in Serum and Virulence

Blankenship, J. R., Wormley, F. L., Boyce, M. K., Schell, W. A., Filler, S. G., Perfect, J. R., & Heitman, J. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.3.422-430.2003 · Cited by 186 · see citing works

Multidrug Resistance in Fungi

Gulshan, K., & Moye-Rowley, S. (2007) · Eukaryotic Cell · doi:10.1128/ec.00254-07 · Cited by 184 · see citing works

A common drug‐responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2 , two genes involved in antifungal drug resistance

de Micheli, M., Billé, J., Schueller, C., & Sanglard, D. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02814.x · Cited by 182 · see citing works

<i>Cryptococcus neoformans</i> Resistance to Echinocandins: (1,3)β-Glucan Synthase Activity Is Sensitive to Echinocandins

Maligie, M. A., & Selitrennikoff, C. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2851-2856.2005 · Cited by 178 · see citing works

International Surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003)

Messer, S. A., Jones, R. N., & Fritsche, T. R. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1782-1787.2006 · Cited by 172 · see citing works

Synergistic Antifungal Activities of Bafilomycin A ₁ , Fluconazole, and the Pneumocandin MK-0991/Caspofungin Acetate (L-743,873) with Calcineurin Inhibitors FK506 and L-685,818 against <i>Cryptococcus neoformans</i>

Del Poeta, M., Cruz, M. C., Cardenas, M. E., Perfect, J. R., & Heitman, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.739-746.2000 · Cited by 169 · see citing works

The Cyclic AMP-Dependent Protein Kinase A Network Regulates Development and Virulence in Aspergillus fumigatus

Liebmann, B., Müller, M., Braun, A. C., & Brakhage, A. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5193-5203.2004 · Cited by 167 · see citing works

Analysis of β-1,3-Glucan Assembly in Saccharomyces cerevisiae Using a Synthetic Interaction Network and Altered Sensitivity to Caspofungin

Lesage, G., Sdicu, A.-M., Ménard, P., Shapiro, J., Hussein, S., & Bussey, H. (2004) · Genetics · doi:10.1534/genetics.167.1.35 · Cited by 166 · see citing works

New targets and delivery systems for antifungal therapy

Walsh, T. J., Viviani, M. A., Arathoon, E., Chiou, C. C., Ghannoum, M. A., Groll, A. H., & Odds, F. C. (2000) · Medical Mycology · doi:10.1080/mmy.38.s1.335.347 · Cited by 162 · see citing works

In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of <i>Candida</i> spp., Including 315 Isolates Resistant to Fluconazole

Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5425-5427.2005 · Cited by 161 · see citing works

Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis

Steinbach, W. J., & Stevens, D. A. (2003) · Clinical Infectious Diseases · doi:10.1086/376523 · Cited by 159 · see citing works

Genetic Architecture of Hsp90-Dependent Drug Resistance

Cowen, L. E., Carpenter, A. E., Matangkasombut, O., Fink, G. R., & Lindquist, S. (2006) · Eukaryotic Cell · doi:10.1128/ec.00274-06 · Cited by 159 · see citing works

The mitogen-activated protein kinase MpkA of Aspergillus fumigatus regulates cell wall signaling and oxidative stress response

Valiante, V., Heinekamp, T., Jain, R., Härtl, A., & Brakhage, A. A. (2007) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2007.09.006 · Cited by 153 · see citing works

In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant Isolates

Pfaller, M. A., Diekema, D. J., Messer, S. A., Hollis, R. J., & Jones, R. N. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1068-1071.2003 · Cited by 152 · see citing works

Evolution of Drug Resistance in <i>Candida Albicans</i>

Cowen, L. E., Anderson, J. B., & Kohn, L. M. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160907 · Cited by 151 · see citing works

In Vitro Evolution of Itraconazole Resistance in Aspergillus fumigatus Involves Multiple Mechanisms of Resistance

Ferreira, M. E. D. S., Capellaro, J. L., Marques, E. D. R., Malavazi, I., Perlin, D. S., Park, S., Anderson, J. B., Colombo, A. L., Arthington, B. A., Goldman, M. H. S., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4405-4413.2004 · Cited by 147 · see citing works

Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models

Odds, F. C., Gerven, F. V., Espinel‐Ingroff, A., Bartlett, M. S., Ghannoum, M. A., Lancaster, M. V., Pfaller, M. A., Rex, J. H., Rinaldi, M. G., & Walsh, T. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.282 · Cited by 146 · see citing works

Acquired itraconazole resistance in Aspergillus fumigatus

Dannaoui, É. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.333 · Cited by 145 · see citing works

Identification and characterization of a <i>Cryptococcus neoformans</i> ATP binding cassette (ABC) transporter‐encoding gene, <i>CnAFR1</i>, involved in the resistance to fluconazole

Posteraro, B., Sanguinetti, M., Sanglard, D., La Sorda, M., Boccia, S., Romano, L., Morace, G., & Fadda, G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03281.x · Cited by 143 · see citing works

A Ser678Pro Substitution in Fks1p Confers Resistance to Echinocandin Drugs in <i>Aspergillus fumigatus</i>

Rocha, E. M. F., Garcia-Effron, G., Park, S., & Perlin, D. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00917-07 · Cited by 141 · see citing works

Population genomics of drug resistance in <i>Candida albicans</i>

Cowen, L. E., Nantel, A., Whiteway, M. S., Thomas, D. Y., Tessier, D. C., Kohn, L. M., & Anderson, J. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102291099 · Cited by 140 · see citing works

Heteroresistance to Fluconazole and Voriconazole in <i>Cryptococcus neoformans</i>

Mondon, P., Petter, R., Amalfitano, G., Luzzati, R., Concia, E., Polacheck, I., & Kwon-Chung, K. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1856 · Cited by 139 · see citing works

G484S Amino Acid Substitution in Lanosterol 14-α Demethylase ( <i>ERG11</i> ) Is Related to Fluconazole Resistance in a Recurrent <i>Cryptococcus neoformans</i> Clinical Isolate

Rodero, L., Mellado, E., Rodriguez, A. C., Salve, A., Guelfand, L., Cahn, P., Cuenca-Estrella, M., Davel, G., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3653-3656.2003 · Cited by 139 · see citing works

Good fungi gone bad: The corruption of calcineurin

Fox, D. S., & Heitman, J. (2002) · BioEssays · doi:10.1002/bies.10157 · Cited by 137 · see citing works

Specific molecular features in the organization and biosynthesis of the cell wall ofAspergillus fumigatus

Latgé, J., Mouyna, I., Tekaia, F., Beauvais, A., Debeaupuis, J. P., & Nierman, W. C. (2005) · Medical Mycology · doi:10.1080/13693780400029155 · Cited by 137 · see citing works

Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies

Kurtz, M., Abruzzo, G. K., Flattery, A. M., Bartizal, K. F., Marrinan, J. A., Li, W., Milligan, J. A., Nollstadt, K. H., & Douglas, C. M. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3244-3251.1996 · Cited by 136 · see citing works

Hsp90: a chaperone for protein folding and gene regulation

Zhao, R., & Houry, W. A. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-158 · Cited by 136 · see citing works

Antibiotic resistance surveillance: action for international studies

Morris, A. K. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.7 · Cited by 136 · see citing works

In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus

Steinbach, W. J., Schell, W. A., Blankenship, J. R., Onyewu, C., Heitman, J., & Perfect, J. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1664-1669.2004 · Cited by 135 · see citing works

Overexpression of<i>Candida albicans CDR1</i>,<i>CDR2</i>, or<i>MDR1</i>Does Not Produce Significant Changes in Echinocandin Susceptibility

Niimi, K., Maki, K., Ikeda, F., Holmes, A. R., Lamping, E., Niimi, M., Monk, B. C., & Cannon, R. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1148-1155.2006 · Cited by 134 · see citing works

Resistance to amphotericin B associated with defective sterol<i>Δ</i>^8→7isomerase in a<i>Cryptococcus neoformans</i>strain from an AIDS patient

Kelly, S. L., Lamb, D. C., Taylor, M., Corran, A. J., Baldwin, B. C., & Powderly, W. G. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07140.x · Cited by 133 · see citing works

Attenuation of the Activity of Caspofungin at High Concentrations against <i>Candida albicans</i> : Possible Role of Cell Wall Integrity and Calcineurin Pathways

Wiederhold, N. P., Kontoyiannis, D. P., Prince, R. A., & Lewis, R. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5146-5148.2005 · Cited by 131 · see citing works

The Effect of the Echinocandin Analogue Caspofungin on Cell Wall Glucan Synthesis byCryptococcus neoformans

Feldmesser, M., Kress, Y., Mednick, A. J., & Casadevall, A. (2000) · The Journal of Infectious Diseases · doi:10.1086/317614 · Cited by 130 · see citing works

A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase

Douglas, C. M., Marrinan, J. A., Li, W., & Kurtz, M. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.18.5686-5696.1994 · Cited by 129 · see citing works

Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus

Tobin, M. B., Peery, R. B., & Skatrud, P. L. (1997) · Gene · doi:10.1016/s0378-1119(97)00281-3 · Cited by 129 · see citing works

Biofilms and their Role in the Resistance of Pathogenic Candida to Antifungal Agents

d’Enfert, C. (2006) · Current Drug Targets · doi:10.2174/138945006776359458 · Cited by 128 · see citing works

Calcineurin, Mpk1 and Hog1 MAPK pathways independently control fludioxonil antifungal sensitivity in Cryptococcus neoformans

Kojima, K., Bahn, Y., & Heitman, J. (2006) · Microbiology · doi:10.1099/mic.0.28571-0 · Cited by 125 · see citing works

Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro

Franzot, S. P., & Casadevall, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.331 · Cited by 124 · see citing works

Fungal ATP-Binding Cassette (ABC) Transporters in Drug Resistance &amp; Detoxification

Sipos, G., & Kuchler, K. (2006) · Current Drug Targets · doi:10.2174/138945006776359403 · Cited by 123 · see citing works

Role of HSP90 in salt stress tolerance via stabilization and regulation of calcineurin.

Imai, J., & Yahara, I. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9262-9270.2000 · Cited by 123 · see citing works

Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon

Liu, T. T., Znaidi, S., Barker, K. S., Xu, L., Homayouni, R., Saidane, S., Morschhäuser, J., Nantel, A., Raymond, M., & Rogers, P. D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00327-07 · Cited by 123 · see citing works

Genomic Approach to Identification of Mutations Affecting Caspofungin Susceptibility in <i>Saccharomyces cerevisiae</i>

Markovich, S., Yekutiel, A., Shalit, I., Shadkchan, Y., & Osherov, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3871-3876.2004 · Cited by 122 · see citing works

The Calcineurin Target, Crz1, Functions in Azole Tolerance but Is Not Required for Virulence of <i>Candida albicans</i>

Onyewu, C., Wormley, F. L., Perfect, J. R., & Heitman, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7330-7333.2004 · Cited by 121 · see citing works

In Vitro Activity of Caspofungin (MK-0991) against Candida albicans Clinical Isolates Displaying Different Mechanisms of Azole Resistance

Bachmann, S. P., Patterson, T. F., & Lopez-Ribot, J. L. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.2228-2230.2002 · Cited by 117 · see citing works

Increased Fluconazole Resistance of Cryptococcus neoformans Isolated from a Patient with AIDS and Recurrent Meningitis

Paugam, A., Dupouy‐Camet, J., Blanche, P., Gangneux, J., Tourte-Schaefer, C., & Sicard, D. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.5.975-a · Cited by 117 · see citing works

Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species

Kontoyiannis, D. P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg090 · Cited by 116 · see citing works

Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to <i>Candida albicans</i>

Marchetti, O., Entenza, J. M., Sanglard, D., Bille, J., Glauser, M. P., & Moreillon, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.2932-2938.2000 · Cited by 113 · see citing works

Divergence in Fitness and Evolution of Drug Resistance in Experimental Populations of Candida albicans

Cowen, L. E., Kohn, L. M., & Anderson, J. B. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.10.2971-2978.2001 · Cited by 113 · see citing works

The Candida albicans Cdr2p ATP‐binding cassette (ABC) transporter confers resistance to caspofungin

Schuetzer‐Muehlbauer, M., Willinger, B., Krapf, G., Enzinger, S., Presterl, E., & Kuchler, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03430.x · Cited by 111 · see citing works

The GPI-anchored protein CaEcm33p is required for cell wall integrity, morphogenesis and virulence in Candida albicans

Martínez‐López, R. (2004) · Microbiology · doi:10.1099/mic.0.27320-0 · Cited by 111 · see citing works

Calcineurin Is Required forCandida albicansTo Survive Calcium Stress in Serum

Blankenship, J. R., & Heitman, J. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.5767-5774.2005 · Cited by 111 · see citing works

Characterization ofAspergillus fumigatusmutants with reduced susceptibility to caspofungin

Gardiner, R. E., Souteropoulos, P., Park, S., & Perlin, D. S. (2005) · Medical Mycology · doi:10.1080/13693780400029023 · Cited by 110 · see citing works

Harmful fungi in both agriculture and medicine.

Lucca, A. J. D. (2007) · PubMed · Cited by 109 · see citing works

Serum Differentially Alters the Antifungal Properties of Echinocandin Drugs

Paderu, P., García‐Effrón, G., Balashov, S. V., Delmas, G., Park, S., & Perlin, D. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01536-06 · Cited by 109 · see citing works

Calcineurin Inhibition or Mutation Enhances Cell Wall Inhibitors against <i>Aspergillus fumigatus</i>

Steinbach, W. J., Cramer, R. A., Perfect, B. Z., Henn, C., Nielsen, K., Heitman, J., & Perfect, J. R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01394-06 · Cited by 108 · see citing works

Stable azole drug resistance associated with a substrain of <i>Candida albicans</i> from an HIV‐infected patient

White, T., Pfaller, M., Rinaldi, M., Smith, J., & Redding, S. (1997) · Oral Diseases · doi:10.1111/j.1601-0825.1997.tb00336.x · Cited by 107 · see citing works

PST1 and ECM33 encode two yeast cell surface GPI proteins important for cell wall integrity

Pardo, M. (2004) · Microbiology · doi:10.1099/mic.0.26924-0 · Cited by 107 · see citing works

Caspofungin Activity against Clinical Isolates of Fluconazole-Resistant Candida

Pfaller, M. A., Messer, S. A., Boyken, L. B., Rice, C., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5729-5731.2003 · Cited by 107 · see citing works

Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection

Johnson, E. M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.1.85 · Cited by 106 · see citing works

Drug resistance in Cryptococcus neoformans

Perfect, J. R., & Cox, G. M. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0090 · Cited by 106 · see citing works

Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans

Krishnarao, T. V., & Galgiani, J. N. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1957 · Cited by 102 · see citing works

Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast

Schuetzer‐Muehlbauer, M. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00213-9 · Cited by 97 · see citing works

Hongos patógenos communes en la Agricultura y la Medicina

Lucca, A. J. D. (2007) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(07)70002-5 · Cited by 97 · see citing works

Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14alpha-demethylase gene, pdmA

Osherov, N. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.75 · Cited by 96 · see citing works

Progressive Esophagitis Caused by Candida albicans with Reduced Susceptibility to Caspofungin

Miller, C., Lomaestro, B. W., Park, S., & Perlin, D. S. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.6.877 · Cited by 93 · see citing works

Deletion of the Regulatory Subunit of Protein Kinase A in Aspergillus fumigatus Alters Morphology, Sensitivity to Oxidative Damage, andVirulence

Zhao, W., Panepinto, J. C., Fortwendel, J. R., Fox, L., Oliver, B. G. G., Askew, D. S., & Rhodes, J. C. (2006) · Infection and Immunity · doi:10.1128/iai.00565-06 · Cited by 93 · see citing works

Structure and Function Analysis of CaMdr1p, a Major Facilitator Superfamily Antifungal Efflux Transporter Protein of Candida albicans : Identification of Amino Acid Residues Critical for Drug/H + Transport

Pasrija, R., Banerjee, D., & Prasad, R. (2007) · Eukaryotic Cell · doi:10.1128/ec.00315-06 · Cited by 91 · see citing works

Risk of resistance associated with fluconazole prophylaxis: Systematic review

Brion, L. P., Uko, S. E., & Goldman, D. L. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.11.017 · Cited by 90 · see citing works

Disruption of the Aspergillus fumigatus ECM33 homologue results in rapid conidial germination, antifungal resistance and hypervirulence

Romano, J., Nimrod, G., Ben‐Tal, N., Shadkchan, Y., Baruch, K., Sharon, H., & Osherov, N. (2006) · Microbiology · doi:10.1099/mic.0.28936-0 · Cited by 88 · see citing works

The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth

Eng, W.-K., Faucette, L. F., McLaughlin, M. M., Cafferkey, R., Koltin, Y., Morris, R. A., Young, P. R., Johnson, R. K., & Livi, G. P. (1994) · Gene · doi:10.1016/0378-1119(94)90633-5 · Cited by 86 · see citing works

Multidrug Resistance inAspergillus fumigatus

Warris, A., Weemaes, C. M. R., & Verweij, P. E. (2002) · New England Journal of Medicine · doi:10.1056/nejm200212263472618 · Cited by 86 · see citing works

Integration of Stress Responses: Modulation of Calcineurin Signaling in Saccharomyces cerevisiae by Protein Kinase A

Kafadar, K. A., & Cyert, M. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.5.1147-1153.2004 · Cited by 85 · see citing works

Cyclic AMP Signaling Pathway Modulates Susceptibility of Candida Species and Saccharomyces cerevisiae to Antifungal Azoles and Other Sterol Biosynthesis Inhibitors

Jain, P., Akula, I., & Edlind, T. D. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3195-3201.2003 · Cited by 82 · see citing works

Cross-resistance to polyene and azole drugs in Cryptococcus neoformans

Joseph‐Horne, T., Hollomon, D. W., Loeffler, R. S. T., & Kelly, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1526 · Cited by 81 · see citing works

Functional characterization of the Candida albicans CRZ1 gene encoding a calcineurin-regulated transcription factor

Santos, M., & de Larrinoa, I. F. (2005) · Current Genetics · doi:10.1007/s00294-005-0003-8 · Cited by 78 · see citing works

Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein.

Rao, U. S. M., & Scarborough, G. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10165-x · Cited by 78 · see citing works

Adaptation to environmental pH: integrating the Rim101 and calcineurin signal transduction pathways

Kullas, A. L., Martin, S. J., & Davis, D. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05929.x · Cited by 75 · see citing works

Aspergillus nidulans is frequently resistant to amphotericin B

Kontoyiannis, D. P., Lewis, R. E., May, G. S., Osherov, N., & Rinaldi, M. G. (2002) · Mycoses · doi:10.1046/j.1439-0507.2002.00797.x · Cited by 75 · see citing works

Fluconazole tolerance in clinical isolates of Cryptococcus neoformans

Venkateswarlu, K., Taylor, M., Manning, N. J., Rinaldi, M. G., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.748 · Cited by 74 · see citing works

Rapid, High-Throughput, Multiplex, Real-Time PCR for Identification of Mutations in the cyp51A Gene of Aspergillus fumigatus That Confer Resistance to Itraconazole

Balashov, S. V., Gardiner, R. E., Park, S., & Perlin, D. S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.214-222.2005 · Cited by 73 · see citing works

Plasmodium falciparum calcineurin and its association with heat shock protein 90: mechanisms for the antimalarial activity of cyclosporin A and synergism with geldanamycin

Kumar, R., Musiyenko, A., & Barik, S. (2005) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2005.01.012 · Cited by 71 · see citing works

Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance

Rognon, B., Kozovska, Z., Coste, A. T., Pardini, G., & Sanglard, D. (2006) · Microbiology · doi:10.1099/mic.0.29277-0 · Cited by 71 · see citing works

Combined Activity In Vitro of Caspofungin, Amphotericin B, and Azole Agents against Itraconazole-Resistant Clinical Isolates of Aspergillus fumigatus

Cuenca‐Estrella, M., Gómez‐López, A., García‐Effrón, G., Alcázar‐Fuoli, L., Mellado, E., Buitrago, M. J., & Rodrı́guez-Tudela, J. L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1232-1235.2005 · Cited by 71 · see citing works

Antifungal Drug Resistance: Molecular Mechanisms in <i>Candida albicans</i> and Beyond

Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801 · see citing works

Mechanisms of Antifungal Drug Resistance

Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647 · see citing works

Efflux-Mediated Antifungal Drug Resistance

Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608 · see citing works

Regulatory circuitry governing fungal development, drug resistance, and disease.

Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576 · see citing works

Cryptococcus neoformans Overcomes Stress of Azole Drugs by Formation of Disomy in Specific Multiple Chromosomes

Sionov, E., Lee, H., Chang, Y. C., & Kwon-Chung, K. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000848 · Cited by 479 · see citing works

Molecular Evolution of Antifungal Drug Resistance

Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441 · see citing works

Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease

Cowen, L. E., Singh, S. D., Köhler, J. R., Collins, C., Zaas, A. K., Schell, W. A., Aziz, H., Mylonakis, E., Perfect, J. R., Whitesell, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813394106 · Cited by 413 · see citing works

Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin

Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R., & Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000532 · Cited by 362 · see citing works

PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90

LaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001069 · Cited by 329 · see citing works

The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus

Fraczek, M. G., Bromley, M., Buied, A., Moore, C. B., Rajendran, R., Rautemaa‐Richardson, R., Ramage, G., Denning, D. W., & Bowyer, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt075 · Cited by 313 · see citing works

Mechanisms of echinocandin antifungal drug resistance

Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313 · see citing works

Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms

Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D., & Cowen, L. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002257 · Cited by 291 · see citing works

Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia

Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270 · see citing works

NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning

Chen, X., Ren, B., Chen, M., Wang, Q., Zhang, L., & Yan, G. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004975 · Cited by 281 · see citing works

Current Perspectives on Echinocandin Class Drugs

Perlin, D. S. (2011) · Future Microbiology · doi:10.2217/fmb.11.19 · Cited by 274 · see citing works

Recent insights into Candida albicans biofilm resistance mechanisms

Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271 · see citing works

Efflux in Fungi: La Pièce de Résistance

Coleman, J. J., & Mylonakis, E. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000486 · Cited by 236 · see citing works

How Sweet it is! Cell Wall Biogenesis and Polysaccharide Capsule Formation in Cryptococcus neoformans

Doering, T. L. (2009) · Annual Review of Microbiology · doi:10.1146/annurev.micro.62.081307.162753 · Cited by 220 · see citing works

Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal

Costa-de-Oliveira, S., & Rodrigues, A. G. (2020) · Microorganisms · doi:10.3390/microorganisms8020154 · Cited by 229 · see citing works

Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata

Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 204 · see citing works

<i>Erg11</i> mutations associated with azole resistance in clinical isolates of <i>Candida albicans</i>

Xiang, M.-J., Liu, J.-Y., Ni, P.-H., Wang, S., Shi, C., Wei, B., Ni, Y.-X., & Ge, H.-L. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12042 · Cited by 197 · see citing works

Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata

Healey, K. R., & Perlin, D. S. (2018) · Journal of Fungi · doi:10.3390/jof4030105 · Cited by 194 · see citing works

Interaction of <i>Candida albicans</i> Biofilms with Antifungals: Transcriptional Response and Binding of Antifungals to Beta-Glucans

Vediyappan, G., Rossignol, T., & d'Enfert, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01638-09 · Cited by 183 · see citing works

Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species

Czajka, K. M., Venkataraman, K., Brabant-Kirwan, D., Santi, S. A., Verschoor, C. P., Appanna, V. D., Singh, R. I., Saunders, D., & Tharmalingam, S. (2023) · Cells · doi:10.3390/cells12222655 · Cited by 196 · see citing works

The Aspergillus fumigatus cell wall integrity signaling pathway: drug target, compensatory pathways, and virulence

Valiante, V., Macheleidt, J., Föge, M., & Brakhage, A. A. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00325 · Cited by 184 · see citing works

Heteroresistance to Fluconazole in <i>Cryptococcus neoformans</i> Is Intrinsic and Associated with Virulence

Sionov, E., Chang, Y. C., Garraffo, H. M., & Kwon-Chung, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-09 · Cited by 179 · see citing works

Identification and Characterization of Four Azole-Resistant <i>erg3</i> Mutants of <i>Candida albicans</i>

Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Rolley, N., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00348-10 · Cited by 168 · see citing works

Update on Antifungal Drug Resistance

Perlin, D. S., Shor, E., & Zhao, Y. (2015) · Current Clinical Microbiology Reports · doi:10.1007/s40588-015-0015-1 · Cited by 174 · see citing works

Antifungal drug resistance of oral fungi

Niimi, M., Firth, N. A., & Cannon, R. D. (2010) · Odontology · doi:10.1007/s10266-009-0118-3 · Cited by 169 · see citing works

Antimicrobial activity of pomegranate peel extracts as affected by cultivar

Rosas‐Burgos, E. C., Burgos‐Hernández, A., Noguera‐Artiaga, L., Kačániová, M., Hernández, F., Cárdenas-López, J. L., & Carbonell-Barrachina, Á. A. (2016) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.7799 · Cited by 167 · see citing works

New pathogens, new tricks: emerging, drug‐resistant fungal pathogens and future prospects for antifungal therapeutics

Geddes‐McAlister, J., & Shapiro, R. S. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 159 · see citing works

Fungistasis and general soil biostasis – A new synthesis

Garbeva, P., Hol, W. H. G., Termorshuizen, A. J., Kowalchuk, G. A., & de Boer, W. (2010) · Soil Biology and Biochemistry · doi:10.1016/j.soilbio.2010.11.020 · Cited by 156 · see citing works

The CWI Pathway: Regulation of the Transcriptional Adaptive Response to Cell Wall Stress in Yeast

Sanz, A., García, R., Rodríguez-Peña, J., & Arroyo, J. (2017) · Journal of Fungi · doi:10.3390/jof4010001 · Cited by 149 · see citing works

A survey of yeast genomic assays for drug and target discovery

Smith, A. M., Ammar, R., Nislow, C., & Giaever, G. N. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.012 · Cited by 131 · see citing works

Rezafungin—Mechanisms of Action, Susceptibility and Resistance: Similarities and Differences with the Other Echinocandins

García‐Effrón, G. (2020) · Journal of Fungi · doi:10.3390/jof6040262 · Cited by 134 · see citing works

Hsp90 orchestrates stress response signaling governing fungal drug resistance

Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000471 · Cited by 130 · see citing works

Candida albicans gains azole resistance by altering sphingolipid composition

Gao, J., Wang, H., Li, Z., Wong, A. H.-H., Wang, Y.-Z., Guo, Y., Lin, X., Zeng, G., Liu, H., Wang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06944-1 · Cited by 130 · see citing works

The role of oxidative and nitrosative bursts caused by azoles and amphotericin B against the fungal pathogen Cryptococcus gattii

Ferreira, G. F., Baltazar, L. D. M., dos Santos, J. R. A., Monteiro, A. S., Fraga, L. A. D. O., de Resende, M. A., & Santos, D. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt114 · Cited by 121 · see citing works

Calcineurin as a multifunctional regulator: Unraveling novel functions in fungal stress responses, hyphal growth, drug resistance, and pathogenesis

Juvvadi, P. R., Lamoth, F., & Steinbach, W. J. (2014) · Fungal Biology Reviews · doi:10.1016/j.fbr.2014.02.004 · Cited by 116 · see citing works

Mapping the Hsp90 genetic interaction network in Candida albicans reveals environmental contingency and rewired circuitry

Diezmann, S., Michaut, M., Shapiro, R. S., Bader, G. D., & Cowen, L. E. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002562 · Cited by 112 · see citing works

Narrow mutational signatures drive acquisition of multidrug resistance in the fungal pathogen Candida glabrata

Ksiezopolska, E., Schikora-Tamarit, M. À., Beyer, R., Nunez-Rodriguez, J. C., Schüller, C., & Gabaldón, T. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.084 · Cited by 107 · see citing works

It’s not magic – Hsp90 and its effects on genetic and epigenetic variation

Zabinsky, R. A., Mason, G. A., Queitsch, C., & Jarosz, D. F. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.05.015 · Cited by 104 · see citing works

Review on Current Status of Echinocandins Use

Mroczyńska, M., & Brillowska‐Dąbrowska, A. (2020) · Antibiotics · doi:10.3390/antibiotics9050227 · Cited by 108 · see citing works

Elucidating Drug Resistance in Human Fungal Pathogens

Xie, J. L., Polvi, E. J., Shekhar‐Guturja, T., & Cowen, L. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.18 · Cited by 98 · see citing works

pH Signaling in Human Fungal Pathogens: a New Target for Antifungal Strategies

Cornet, M., & Gaillardin, C. M. (2014) · Eukaryotic Cell · doi:10.1128/ec.00313-13 · Cited by 99 · see citing works

Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations

Hill, J. A., Ammar, R., Torti, D., Nislow, C., & Cowen, L. E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003390 · Cited by 93 · see citing works

The fungal Achilles’ heel: targeting Hsp90 to cripple fungal pathogens

Cowen, L. E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.005 · Cited by 93 · see citing works

Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi

Hokken, M., Zwaan, B. J., Melchers, W. J. G., & Verweij, P. E. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103254 · Cited by 94 · see citing works

Reversion of a fungal genetic code alteration links proteome instability with genomic and phenotypic diversification

Bezerra, A. R., Simões, J., Lee, W., Rung, J., Weil, T., Gut, I. G., Gut, M., Bayés, M., Rizzetto, L., Cavalieri, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302094110 · Cited by 92 · see citing works

Role of Ndt80p in Sterol Metabolism Regulation and Azole Resistance in <i>Candida albicans</i>

Sellam, A., Tebbji, F., & Nantel, A. (2009) · Eukaryotic Cell · doi:10.1128/ec.00074-09 · Cited by 91 · see citing works

The Hsp90 chaperone network modulates Candida virulence traits

O’Meara, T. R., Robbins, N., & Cowen, L. E. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.05.003 · Cited by 92 · see citing works

The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility

Yan, L., Li, M., Cao, Y., Gao, P., Cao, Y., Wang, Y., & Jiang, Y. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp273 · Cited by 89 · see citing works

The Hsp90 Co-Chaperone Sgt1 Governs Candida albicans Morphogenesis and Drug Resistance

Shapiro, R. S., Zaas, A. K., Betancourt-Quiroz, M., Perfect, J. R., & Cowen, L. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044734 · Cited by 86 · see citing works

Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis

Murphy, S. E., & Bicanic, T. A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.759408 · Cited by 85 · see citing works

A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates

Bhattacharya, S., Sobel, J. D., & White, T. C. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01252-16 · Cited by 83 · see citing works

The effect of biomaterials and antifungals on biofilm formation by Candida species: a review

Cuéllar‐Cruz, M., Vega‐González, A., Mendoza‐Novelo, B., López-Romero, E., Ruiz‐Baca, E., Escorza, M. A. Q., & Villagómez-Castro, J. C. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1634-6 · Cited by 82 · see citing works

Adaptative survival of Aspergillus fumigatus to echinocandins arises from cell wall remodeling beyond β−1,3-glucan synthesis inhibition

Dickwella Widanage, M. C., Gautam, I., Sarkar, D., Mentink-Vigier, F., Vermaas, J. V., Ding, S.-Y., Lipton, A. S., Fontaine, T., Latgé, J.-P., Wang, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50799-8 · Cited by 70 · see citing works

Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing

Braga, S. S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111660 · Cited by 79 · see citing works

Fungal strategies for dealing with environment- and agriculture-induced stresses

Rangel, D. E. N., Finlay, R. D., Hallsworth, J. E., Dadachova, E., & Gadd, G. M. (2018) · Fungal Biology · doi:10.1016/j.funbio.2018.02.002 · Cited by 78 · see citing works

Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles

Elias, R., Benhamou, R. I., Jaber, Q. Z., Dorot, O., Zada, S. L., Oved, K., Pichinuk, E., & Fridman, M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.003 · Cited by 75 · see citing works

Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis

Campoli, P., Abdallah, Q. A., Robitaille, R., Solis, N. V., Fielhaber, J. A., Kristof, A. S., Laverdière, M., Filler, S. G., & Sheppard, D. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00637-11 · Cited by 77 · see citing works

Multilocus resistance evolution to azole fungicides in fungal plant pathogen populations

Mohd‐Assaad, N., McDonald, B. A., & Croll, D. (2016) · Molecular Ecology · doi:10.1111/mec.13916 · Cited by 73 · see citing works

In Vitro Interactions between Aspirin and Amphotericin B against Planktonic Cells and Biofilm Cells of Candida albicans and C. parapsilosis

Zhou, Y., Wang, G., Li, Y., Liu, Y., Song, Y., Zheng, W., Zhang, N., Hu, X., Shikun, Y., & Jia, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06082-11 · Cited by 72 · see citing works

Coping with Stress and the Emergence of Multidrug Resistance in Fungi

Shor, E., & Perlin, D. S. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004668 · Cited by 71 · see citing works

Candida albicans Ume6, a Filament-Specific Transcriptional Regulator, Directs Hyphal Growth via a Pathway Involving Hgc1 Cyclin-Related Protein

Carlisle, P. L., & Kadosh, D. (2010) · Eukaryotic Cell · doi:10.1128/ec.00046-10 · Cited by 71 · see citing works

Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms

Rane, H. S., Bernardo, S. M., Howell, A. B., & Lee, S. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt398 · Cited by 69 · see citing works

Cell wall integrity and high osmolarity glycerol pathways are required for adaptation of Alternaria brassicicola to cell wall stress caused by brassicaceous indolic phytoalexins

Joubert, A., Bataillé‐Simoneau, N., Campion, C., Guillemette, T., Hudhomme, P., Iacomı, B., Leroy, T., Pochon, S., Poupard, P., & Simoneau, P. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01520.x · Cited by 68 · see citing works

A novel connection between the Cell Wall Integrity and the PKA pathways regulates cell wall stress response in yeast

García, R., Bravo, E., Díez-Muñiz, S., Nombela, C., Rodríguez-Peña, J. M., & Arroyo, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-06001-9 · Cited by 66 · see citing works

Eradication of Candida albicans persister cell biofilm by the membranotropic peptide gH625

Galdiero, E., de Alteriis, E., De Natale, A., D’Alterio, A., Siciliano, A., Guida, M., Lombardi, L., Falanga, A., & Galdiero, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-62746-w · Cited by 65 · see citing works

Heat Shock Protein 90 (Hsp90) as a Molecular Target for the Development of Novel Drugs Against the Dermatophyte Trichophyton rubrum

Jacob, T. R., Peres, N. T. A., Martins, M. P., Lang, E. A. S., Sanches, P. R., Rossi, A., & Martinez-Rossi, N. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01241 · Cited by 65 · see citing works

Tacrolimus Enhances the Potency of Posaconazole Against Rhizopus oryzae In Vitro and in an Experimental Model of Mucormycosis

Lewis, R. E., Ben‐Ami, R., Best, L., Albert, N. D., Walsh, T. J., & Kontoyiannis, D. P. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis767 · Cited by 63 · see citing works

Reverse Genetics in Candida albicans Predicts ARF Cycling Is Essential for Drug Resistance and Virulence

Epp, E., Vanier, G., Harcus, D., Lee, A. Y., Jansen, G., Hallett, M., Sheppard, D. C., Thomas, D. Y., Munro, C. A., Mullick, A., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000753 · Cited by 61 · see citing works

The Involvement of the Mid1/Cch1/Yvc1 Calcium Channels in Aspergillus fumigatus Virulence

de Castro, P. A., Chiaratto, J., Winkelströter, L. K., Bom, V. L. P., Ramalho, L. N. Z., Goldman, M. H. S., Brown, N. A., & Goldman, G. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103957 · Cited by 60 · see citing works

Candida albicans Flu1-Mediated Efflux of Salivary Histatin 5 Reduces Its Cytosolic Concentration and Fungicidal Activity

Li, R. Q., Kumar, R., Tati, S., Puri, S., & Edgerton, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02295-12 · Cited by 59 · see citing works

Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata

Tscherner, M., Schwarzmüller, T., & Kuchler, K. (2011) · Pharmaceuticals · doi:10.3390/ph4010169 · Cited by 60 · see citing works

Influence of Culture Media on Biofilm Formation by Candida Species and Response of Sessile Cells to Antifungals and Oxidative Stress

Serrano‐Fujarte, I., López-Romero, E., Reyna-López, G. E., Martínez-Gámez, M. A., Vega‐González, A., & Cuéllar‐Cruz, M. (2015) · BioMed Research International · doi:10.1155/2015/783639 · Cited by 58 · see citing works

Overcoming Fungal Echinocandin Resistance through Inhibition of the Non-essential Stress Kinase Yck2

Caplan, T., Lorente-Macías, Á., Stogios, P. J., Evdokimova, E., Hyde, S., Wellington, M. A., Liston, S., Iyer, K. R., Puumala, E., Shekhar-Guturja, T., et al. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.12.008 · Cited by 57 · see citing works

In vitro efficacy of nisin Z against Candida albicans adhesion and transition following contact with normal human gingival cells

Akerey, B., Le-Lay, C., Fliss, I., Subirade, M., & Rouabhia, M. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04312.x · Cited by 56 · see citing works

The effect of antifungal resistance development on the virulence of Candida species

Bohner, F., Papp, C., & Gácser, A. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac019 · Cited by 62 · see citing works

Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in <i>Candida albicans</i>

Todd, R. T., Soisangwan, N., Peters, S., Kemp, B., Crooks, T., Gerstein, A., & Selmecki, A. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad009 · Cited by 53 · see citing works

Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis

Rybak, J. M., Dickens, C. M., Parker, J. E., Caudle, K. E., Manigaba, K., Whaley, S. G., Nishimoto, A. T., Luna-Tapia, A., Roy, S., Zhang, Q., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00651-17 · Cited by 53 · see citing works

Heat shock protein 90 from neglected protozoan parasites

Roy, N., Nageshan, R. K., Ranade, S., & Tatu, U. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.12.003 · Cited by 54 · see citing works

Erg6 affects membrane composition and virulence of the human fungal pathogen Cryptococcus neoformans

de Oliveira, F. F. M., Paes, H. C., Peconick, L. D. F., Fonseca, F. L., Marina, C. L., Bocca, A. L., Homem-de-Mello, M., Rodrigues, M. L., Albuquerque, P., Nicola, A. M., et al. (2020) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2020.103368 · Cited by 50 · see citing works

Mechanistic Insight into Antimicrobial and Antioxidant Potential of Jasminum Species: A Herbal Approach for Disease Management

Balkrishna, A., Rohela, A., Kumar, A., Kumar, A., Arya, V., Thakur, P., Olekšák, P., Krejcar, O., Verma, R., Kumar, D., et al. (2021) · Plants · doi:10.3390/plants10061089 · Cited by 58 · see citing works

Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection

Pais, P., Galocha, M., Viana, R., Cavalheiro, M., Pereira, D., & Teixeira, M. C. (2019) · Microbial Cell · doi:10.15698/mic2019.03.670 · Cited by 52 · see citing works

Alternate Strategies of Hsp90 Modulation for the Treatment of Cancer and Other Diseases

Brandt, G. E. L., & Blagg, B. S. J. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789895683 · Cited by 50 · see citing works

Cyclic Colisporifungin and Linear Cavinafungins, Antifungal Lipopeptides Isolated fromColispora cavincola

Ortiz‐López, F. J., Monteiro, M. C., González-Menéndez, V., Tormo, J. R., Genilloud, O., Bills, G. F., Vicente, F., Zhang, C., Roemer, T., Singh, S. B., et al. (2015) · Journal of Natural Products · doi:10.1021/np500854j · Cited by 50 · see citing works

Candida albicans VMA3 Is Necessary for V-ATPase Assembly and Function and Contributes to Secretion and Filamentation

Rane, H. S., Bernardo, S. M., Raines, S. M., Binder, J., Parra, K. J., & Lee, S. A. (2013) · Eukaryotic Cell · doi:10.1128/ec.00118-13 · Cited by 49 · see citing works

Terbinafine Resistance in Trichophyton rubrum and Trichophyton indotineae: A Literature Review

Gupta, A. K., Susmita, S., Nguyen, H. C., Liddy, A., Economopoulos, V., & Wang, T. (2025) · Antibiotics · doi:10.3390/antibiotics14050472 · Cited by 48 · see citing works

The Zinc Finger Protein Mig1 Regulates Mitochondrial Function and Azole Drug Susceptibility in the Pathogenic Fungus Cryptococcus neoformans

Caza, M., Hu, G., Price, M., Perfect, J. R., & Kronstad, J. W. (2016) · mSphere · doi:10.1128/msphere.00080-15 · Cited by 48 · see citing works

Histatin 5 Metallopeptides and Their Potential against Candida albicans Pathogenicity and Drug Resistance

Zolin, G. V. S., da Fonseca, F. H., Zambom, C. R., & Garrido, S. S. (2021) · Biomolecules · doi:10.3390/biom11081209 · Cited by 46 · see citing works

Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans

Lee, H., Lamichhane, A. K., Garraffo, H. M., Kwon-Chung, K. J., & Chang, Y. C. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08016.x · Cited by 47 · see citing works

Variability of the Stripe Rust Pathogen

Wan, A., Wang, X., Kang, Z., & Chen, X. (2017) · Springer eBooks · doi:10.1007/978-94-024-1111-9_2 · Cited by 47 · see citing works

Functional Characterization of Calcineurin Homologs PsCNA1/PsCNB1 in Puccinia striiformis f. sp. tritici Using a Host-Induced RNAi System

Zhang, H., Guo, J., Voegele, R. T., Zhang, J., Duan, Y., Luo, H., & Kang, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049262 · Cited by 46 · see citing works

Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans

Feng, W., Yang, H. J., Xi, Z., Qiao, Z., Lv, Y., Wang, Y., Ma, Y., Wang, Y., & Wen, C. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0095 · Cited by 45 · see citing works

Progress and prospects for targeting Hsp90 to treat fungal infections

Veri, A. O., & Cowen, L. E. (2014) · Parasitology · doi:10.1017/s0031182013002072 · Cited by 43 · see citing works

Emerging Mechanisms of Drug Resistance in Candida albicans

Prasad, R., Nair, R., & Banerjee, A. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_6 · Cited by 43 · see citing works

Candida albicans autophagy, no longer a bystander: Its role in tolerance to ER stress-related antifungal drugs

Yu, Q., Jia, C., Dong, Y., Zhang, B., Xiao, C., Chen, Y., Wang, Y., Li, X., Wang, L., Zhang, B., et al. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.02.008 · Cited by 42 · see citing works

Evolutionary divergence in the fungal response to fluconazole revealed by soft clustering

Kuo, D., Tan, K., Zinman, G., Ravasi, T., Bar‐Joseph, Z., & Ideker, T. E. (2010) · Genome biology · doi:10.1186/gb-2010-11-7-r77 · Cited by 40 · see citing works

Metabolic control of antifungal drug resistance

Robbins, N., Collins, C., Morhayim, J., & Cowen, L. E. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.07.004 · Cited by 40 · see citing works

Signalling mechanisms involved in stress response to antifungal drugs

Víglaš, J., & Olejníková, P. (2020) · Research in Microbiology · doi:10.1016/j.resmic.2020.10.001 · Cited by 23 · see citing works

Flipped Out

(2006) · Science · doi:10.1126/science.312.5775.815b

Antibiotics: Precious Goods in Changing Times

Saß, P. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6634-9_1 · Cited by 8 · see citing works

Activation of stress signalling pathways enhances tolerance of fungi to chemical fungicides and antifungal proteins

Hayes, B. M. E., Anderson, M. A., Traven, A., van der Weerden, N. L., & Bleackley, M. R. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1573-8 · Cited by 93 · see citing works

Drug Resistance: An Incessant Fight against Evolutionary Strategies of Survival

Ramos‐Martín, F., & D’Amelio, N. (2023) · Microbiology Research · doi:10.3390/microbiolres14020037 · Cited by 50 · see citing works